Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults

Journal of Infection

Volumn 61, Issue 5, 2010, Pages 403-409

  Troughton, Judith A ^a   Browne, Gail ^a   McAuley, Danny F ^a,b   Walker, M James ^a   Patterson, Christopher C ^b   McMullan, Ronan ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Anti fungal; Candidaemia; Colonisation; ICU; Pre emptive therapy

Indexed keywords

FLUCONAZOLE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDEMIA; CRITICAL ILLNESS; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; ANTIFUNGAL AGENTS; APACHE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDEMIA; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; GREAT BRITAIN; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78149322297     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.08.013     Document Type: Article

References (30)

1. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA 1995, 274:639-644.
2. Leleu G., Aegerter P., Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002, 17:168-175.
3. Blot S.I., Vandewoude K.H., Hoste E.A., Colardyn F.A. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002, 113:480-485.
4. Pittet D., Monod M., Suter P.M., Frenk E., Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220:751-758.
5. Eggimann P., Garbino J., Pittet D. Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003, 3:772-785.
6. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161-189.
7. Piarroux R., Grenouillet F., Balvay P., Tran V., Blasco G., Millon L., et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004, 32:2443-2449.
8. Munoz P., Burillo A., Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 2000, 15:83-90.
9. Blot S., Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs 2004, 64:2159-2175.
10. Pfaller M.A., Diekema D.J., Jones R.N., Sader H.S., Fluit A.C., Hollis R.J., et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001, 39:3254-3259.
11. Leon C., Alvarez-Lerma F., Ruiz-Santana S., Leon M.A., Nolla J., Jorda R., et al. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 2008, [Epub 2008 Aug 29].
12. Ruan S.Y., Lee L.N., Jerng J.S., Yu C.J., Hsueh P.R. Candida glabrata fungaemia in intensive care units. Clin Microbiol Infect 2008, 14:136-140.
13. Nguyen M.H., Peacock J.E., Morris A.J., Tanner D.C., Nguyen M.L., Snydman D.R., et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996, 100:617-623.
14. Blot S., Vandewoude K., Hoste E., Poelaert J., Colardyn F. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata. J Hosp Infect 2001, 47:308-313.
15. Playford E.G., Webster A.C., Sorrell T.C., Craig J.C. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006, 57:628-638.
16. Trick W.E., Fridkin S.K., Edwards J.R., Hajjeh R.A., Gaynes R.P. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002, 35:627-630.
17. Blumberg H.M., Jarvis W.R., Soucie J.M., Edwards J.E., Patterson J.E., Pfaller M.A., et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001, 33:177-186.
18. Lin M.Y., Carmeli Y., Zumsteg J., Flores E.L., Tolentino J., Sreeramoju P., et al. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrobial Agents Chemother 2005, 49:4555-4560.
19. Pfaller M.A., Messer S.A., Houston A., Rangel-Frausto M.S., Wiblin T., Blumberg H.M., et al. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 1998, 31:289-296.
20. Reagan D.R., Pfaller M.A., Hollis R.J., Wenzel R.P. Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit. Diagn Microbiol Infect Dis 1995, 21:191-194.
21. Vazquez J.A., Sanchez V., Dmuchowski C., Dembry L.M., Sobel J.D., Zervos M.J. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993, 168:195-201.
22. Nucci M., Anaissie E. Revisiting the source of candidemia: skin or gut?. Clin Infect Dis 2001, 33:1959-1967.
23. Reagan D.R., Pfaller M.A., Hollis R.J., Wenzel R.P. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990, 28:2733-2738.
24. Pelz R.K., Lipsett P.A., Swoboda S.M., Diener-West M., Hammond J.M., Hendrix C.W. The diagnostic value of fungal surveillance cultures in critically ill patients. Surg Infect (Larchmt) 2000, 1:273-281.
25. Solomkin J.S., Flohr A.M., Simmons R.L. Indications for therapy for fungemia in postoperative patients. Arch Surg 1982, 117:1272-1275.
26. Slotman G.J., Shapiro E., Moffa S.M. Fungal sepsis: multisite colonization versus fungemia. Am Surg 1994, 60:107-113.
27. Leon C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla-Salas J., Alvarez-Lerma F., et al. A bedside scoring system (" Candida score" ) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34:730-737.
28. Blot S., Dimopoulos G., Rello J., Vogelaers D. Is Candida really a threat in the ICU?. Curr Opin Crit Care 2008, 14:600-604.
29. Eggimann P., Garbino J., Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003, 3:685-702.
30. Pappas P.G., Rex J.H., Lee J., Hamill R.J., Larsen R.A., Powderly W., et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003, 37:634-643.